Methadone Macarthys Laboratories

Methadone Hydrochloride, the active ingredient in Methadone Macarthys Laboratories, is an opioid presented as an injection for intramuscular and subcutaneous use. It is employed to manage severe pain and to support opioid dependence maintenance therapy in appropriate patients.

GNH USA supplies Methadone Macarthys Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methadone is an opioid analgesic used in the management of pain and opioid dependence.

- Severe pain: provides long‑acting analgesia for patients with chronic or breakthrough severe pain. - Opioid dependence maintenance therapy: reduces withdrawal symptoms and cravings in individuals undergoing opioid substitution treatment.

Methadone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Drowsiness: sedation or feeling of fatigue. - Nausea: upset stomach and possible vomiting. - Sweating: increased perspiration without exertion.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia. - Seizures: rare occurrence of convulsive episodes. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting.

When prescribing methadone injection, clinicians should observe several safety measures to minimize risk.

- Assess opioid tolerance: confirm patient has prior opioid exposure before initiating therapy. - Monitor respiratory function: watch for signs of depression, especially after dose changes. - Evaluate cardiac risk: obtain baseline ECG to detect QT prolongation. - Avoid use in acute intoxication: do not administer to patients with recent alcohol or sedative overdose. - Counsel on dependence potential: inform patients about the risk of physical dependence and withdrawal. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Methadone interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression. - MAO inhibitors: can precipitate severe hypotension or serotonin syndrome. - QT‑prolonging drugs (e.g., certain antiarrhythmics, macrolide antibiotics): increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise methadone plasma levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy by lowering concentrations. - Anticholinergic agents: may exacerbate constipation.